Welcome to LookChem.com Sign In|Join Free

CAS

  • or
[10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate is a complex steroidal compound that has been modified by the attachment of a 3,5-dinitrobenzoate group. This modification may confer unique physical and chemical properties to the molecule, which could be explored for various applications. As a steroid, it possesses a diverse range of biological activities, and further research is required to elucidate its specific effects and potential uses.

25279-63-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 25279-63-4 [10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate

    Cas No: 25279-63-4

  • USD $ 1000.0-1000.0 / Kilogram

  • 1 Kilogram

  • 1 Metric Ton/Day

  • HENAN NEW BLUE CHEMICAL CO.,LTD
  • Contact Supplier
  • [10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate

    Cas No: 25279-63-4

  • USD $ 10.0-10.0 / Milligram

  • 1 Milligram

  • 100000000 Kilogram/Month

  • weifang yangxu group co.,ltd
  • Contact Supplier
  • 25279-63-4 Structure
  • Basic information

    1. Product Name: [10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate
    2. Synonyms: 3beta-cholest-5-en-3-ol 3,5-dinitrobenzoate;Cholesterol 3,5-dinitrobenzoate;[10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate;3,5-Dinitrobenzoic acid cholest-5-en-3β-yl ester;Cholest-5-en-3-ol (3beta)-, 3-(3,5-dinitrobenzoate);Cholest-5-en-3-ol (3beta)-, 3,5-dinitrobenzoate
    3. CAS NO:25279-63-4
    4. Molecular Formula: C34H48N2O6
    5. Molecular Weight: 580.75
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 25279-63-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 649.1 °C at 760 mmHg
    3. Flash Point: 200.7 °C
    4. Appearance: /
    5. Density: 1.17 g/cm3
    6. Vapor Pressure: 9.87E-17mmHg at 25°C
    7. Refractive Index: 1.569
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: [10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate(CAS DataBase Reference)
    11. NIST Chemistry Reference: [10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate(25279-63-4)
    12. EPA Substance Registry System: [10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate(25279-63-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 25279-63-4(Hazardous Substances Data)

25279-63-4 Usage

Uses

Used in Pharmaceutical Industry:
[10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate is used as a pharmaceutical agent for its potential therapeutic effects. [10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate's steroidal nature and the addition of the 3,5-dinitrobenzoate group may provide novel biological activities that can be harnessed for the treatment of various diseases and conditions.
Used in Research and Development:
In the field of research and development, [10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate serves as a valuable compound for studying the effects of structural modifications on the properties and activities of steroids. This can lead to the discovery of new drugs and therapeutic agents with improved efficacy and reduced side effects.
Used in Chemical Synthesis:
[10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate can be utilized as a key intermediate in the synthesis of other complex organic compounds. Its unique structure and functional groups make it a potentially useful building block for the development of new molecules with specific properties and applications.
Used in Analytical Chemistry:
[10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate can also be employed in analytical chemistry as a reference material or standard for the development and validation of analytical methods. Its complex structure and unique properties can be used to test the performance of various analytical techniques, such as chromatography, mass spectrometry, and nuclear magnetic resonance spectroscopy.

Check Digit Verification of cas no

The CAS Registry Mumber 25279-63-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,2,7 and 9 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 25279-63:
(7*2)+(6*5)+(5*2)+(4*7)+(3*9)+(2*6)+(1*3)=124
124 % 10 = 4
So 25279-63-4 is a valid CAS Registry Number.
InChI:InChI=1/C34H48N2O6/c1-21(2)7-6-8-22(3)29-11-12-30-28-10-9-24-19-27(13-15-33(24,4)31(28)14-16-34(29,30)5)42-32(37)23-17-25(35(38)39)20-26(18-23)36(40)41/h9,17-18,20-22,27-31H,6-8,10-16,19H2,1-5H3

25279-63-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name [10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3,5-dinitrobenzoate

1.2 Other means of identification

Product number -
Other names Cholesterol 3,5-dinitrobenzoate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25279-63-4 SDS

25279-63-4Relevant articles and documents

PHOTOALIGNING MATERIAL

-

Page/Page column 51, (2013/03/26)

The present invention relates to a copolymer for the photoalignment of liquid crystals comprising a photoreactive group as given below in formula (I), compositions thereof, and its use for optical and electro optical devices, especially liquid crystal dev

Potassium borohydride reductions of immobilised ketosteroids

Briggs, Josie C.,Hodge, Philip,Zhengpu, Zhang

, p. 3943 - 3956 (2007/10/03)

Ketosteroids absorbed into various insoluble supports (powdered polyethylene, microporous 2% crosslinked polystyrene beads, macroporous highly crosslinked polystyrene beads, silica gel and alumina) call be reduced using aqueous potassium barohydride. The use of phase transfer catalysts generally raises yields. In the case of 6-ketosteriods the supported reactions often follow a stereochemical course significantly different from that of analogous reactions in solution. This is attributed to the adsorbtion of the steroid onto the inner surfaces of the supports. In these cases reduction of (he ketosteroid by alkoxyborohydrides is substantially suppressed and thus most of the reduction is brought about by BH4- itself, a relatively sterically undemanding reductant. The net result is that whilst reductions of 6-ketosteroids in solution by potassium borohydride typically gives the 69α- and 6β-alcohols in the ratio 15:85, with the supported steroid the ratios can be as high as 90:10.

Spectroscopic and Molecular Mechanics Calculations of Discrimination between Enantiomers Possessing an Electron Rich Aromatic Group Directly Attached to the Chiral Carbon Atom with Optically Pure Benzoyl Derivatives

Jursic, Branko S.

, p. 961 - 970 (2007/10/02)

The discrimination between enantiomers that have a chiral centre directly attached to the electron rich aromatic ring by interactions with optically pure electron deficient aromatic compounds was studied by 1H NMR and molecular mechanics calculations.The enantiomeric spectroscopic discrimination is due to formation of non-bonding interactions which lead to the formation of diastereoisomeric complexes.The calculated HOMO energy values for electron rich racemic compounds and LUMO values for electron poor resolving agents are in good agreement with the observed chemicalshift differences between enantiomers by 1H NMR.Exceptions to these observations are seen for compounds which possess groups that are in a position to sterically push apart the complexation components and thus decrease the binding energy and diminish the enantiomeric discrimination.The discrimination strongly depends on concentration of the components in the solution, their ratio, temperature and the polarity of the media.Polar racemic compounds show the smallest enantiomeric discrimination by increasing the polarity of the media.For good enantiomeric discrimination both chiral centres must be rigidly bound to the aromatic rings.If the chiral centre is separated from the aromatic ring by flexible bonds the enantiomeric recognition fails despite the formation of strong non-bonding interactions.The binding energies calculated by AMBER and MM + force fields are relatively weak (ca. 2 kcal mol-1) suggesting that only a small portion of the molecules in solution are incorporated into the complexes.Our attempt to provide evidence for selective binding of only one enantiomer to the template molecule was unsuccessful.Neverthelessour results support the formation of inter-exchangeable diastereomeric complexes.Although it might be argued that two sets of signals should also be obtained for the template molecule, all our 1H NMR spectra show only one set of signals for the optically pure template and two sets of signals for the racemic component in their chloroform solutions.Despite low binding energies enantiomeric discrimination with strong electron accepting resolving agents can be achieved in as low as 0.01 mol dm-3 chloroform solution.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 25279-63-4